Galera Therapeutics, Inc.

Galera Therapeutics, Inc.verified

GRTX

Price:

$0.092

Market Cap:

$6.98M

Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The comp...[Read more]

Industry

Biotechnology

IPO Date

2019-11-07

Stock Exchange

OTC

Ticker

GRTX

The ROE as of June 2026 (TTM) for Galera Therapeutics, Inc. (GRTX) is -210.64%

According to Galera Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -210.64%. This represents a change of -136.52% compared to the average of 576.70% of the last 4 quarters.

Galera Therapeutics, Inc. (GRTX) Historical ROE (quarterly & annually)

How has GRTX ROE performed in the past?

The mean historical ROE of Galera Therapeutics, Inc. over the last ten years is 143.90%. The current -210.64% ROE has changed -246.38% with respect to the historical average. Over the past ten years (40 quarters), GRTX's ROE was at its highest in in the December 2025 quarter at 2.34%. The ROE was at its lowest in in the December 2020 quarter at -327.97%.

Quarterly (TTM)
Annual

Average

143.90%

Median

30.94%

Minimum

-1213.11%

Maximum

2.28%

Galera Therapeutics, Inc. (GRTX) ROE by Quarter and Year

Discovering the peaks and valleys of Galera Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 17.14%

Maximum Annual ROE = 2.28%

Minimum Annual Increase = -430.29%

Minimum Annual ROE = -1213.11%

Quarterly (TTM)
Annual
YearROEChange
20252.28%17.14%
202413.19%-70.70%
202345.04%-20.97%
202256.99%-58.95%
2021138.84%-111.45%
2020-1213.11%1.53%
2019-74.60%-430.29%
201822.59%-26.99%

Galera Therapeutics, Inc. (GRTX) Average ROE

How has GRTX ROE performed in the past?

The current ROE of Galera Therapeutics, Inc. (GRTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

777.81%

5-year avg

505.85%

10-year avg

143.90%

Galera Therapeutics, Inc. (GRTX) ROE vs. Peers

How is GRTX’s ROE compared to its peers?

Galera Therapeutics, Inc.’s ROE is less than Health Sciences Group, Inc. (2.53%), greater than Medigene AG (-55.69%), less than Agentix Corp. (17.76%), less than Stemcell Holdings, Inc. (93.24%), less than Neon Bloom, Inc. (13.99%), less than Vaccinex, Inc. (776.58%), less than Aion Therapeutic Inc. (190.59%), less than Ember Therapeutics, Inc. (10.25%), greater than Hemp, Inc (-38.72%), less than Assure Holdings Corp. (528.43%),

Build a custom stock screener for Galera Therapeutics, Inc. (GRTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Galera Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Galera Therapeutics, Inc. (GRTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Galera Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Galera Therapeutics, Inc.'s ROE?

How is the ROE calculated for Galera Therapeutics, Inc. (GRTX)?

What is the highest ROE for Galera Therapeutics, Inc. (GRTX)?

What is the 3-year average ROE for Galera Therapeutics, Inc. (GRTX)?

What is the 5-year average ROE for Galera Therapeutics, Inc. (GRTX)?

How does the current ROE for Galera Therapeutics, Inc. (GRTX) compare to its historical average?